Thank you, Mr. Weston.
I thank the committee for generously giving me a slot so that I can ask questions.
Dr. Tamblyn, you have talked about research, the consumer, and industry. I'm going to direct this question to you, if I may. I'm very interested in what you had to say about how we need to go forward in terms of developing the research and about the practicalities of modifying the health care delivery in such a way that we can reach more people faster, so that people can be empowered, basically, to help themselves. That's what we're doing.
I was wondering if in your research you have coordinated or collaborated with other countries, such as Israel and Sweden. I've had quite a bit of dialogue from those two countries recently, and smatterings of some of the things you've said today have had that kind of delivery in those countries. Could you elaborate a bit on that?